Abrahmsen Lars B.

SVP, Chief Scientific Officer at APRE

Sold, on record
$369k
Dollars the filings state
Form 4 sales
2
Latest Oct 1, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • APREAprea Therapeutics, Inc.SVP, Chief Scientific Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale APREUnusual
    Sep 20 2021

    Sold 25,000 shares at $4.97 ($124k)

    Abrahmsen Lars B., SVP, Chief Scientific Officer

    Sold 56.8% of holdings ($219k position)19,000 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale APREUnusual
    Oct 1 +11 days

    Sold 50,000 shares at $4.89 ($244k)

    Abrahmsen Lars B., SVP, Chief Scientific Officer

    Sold 72.5% of holdings ($337k position)19,000 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Abrahmsen Lars B.
Source
Oct 1, 2021APRESVP, Chief Scientific OfficerForm 4 sale50,000$244k72.5%UnusualSEC
Sep 20, 2021APRESVP, Chief Scientific OfficerForm 4 sale25,000$124k56.8%UnusualSEC